Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones11-28

This article was automatically generated using Dow Jones technology.

Shares of Genmab A/S rose 2.1% to DKK1,488.00 Wednesday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 0.3% to 2,595.10.

The stock's rise snapped a two-day losing streak.

The company closed DKK795.00 short of its 52-week high of DKK2,283.00, which the company achieved on December 11, 2023.

Trading volume was 69,953, compared to the 50-day average trading volume of 109,095.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

November 27, 2024 12:02 ET (17:02 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment